IL6 and hepatocellular carcinoma: The study of Zhang et al. indicated that in hepatocellular carcinoma, serum IL-6 could upregulate PD-L1 expression in macrophages, which in turn caused immunosuppression in an orthotopic tumor transplantation model [38].